In Reply: Deprenyl and the Progression of Parkinson's Disease

Science - United States
doi 10.1126/science.249.4966.303-b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Editorial: Parkinson's Disease: Cell Vulnerability and Disease Progression

Frontiers in Neuroanatomy
AnatomyNeuroscienceCellularMolecular Neuroscience
2015English

Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.

Internal Medicine
Internal MedicineMedicine
1994English

Differences in the Presentation and Progression of Parkinson's Disease by Sex

2020English

Insomnia in Parkinson's Disease: Frequency and Progression Over Time

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2006English

115 Systematic Review of Biomarkers for Disease Progression in Parkinson's Disease

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2012English

Gut Microbiota in Parkinson's Disease: Temporal Stability and Relations to Disease Progression

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Dopamine Transporter Imaging Assessment of Parkinson's Disease Progression

2000English

Cognitive Decline Before Diagnosis of Parkinson's Disease – Authors' Reply

The Lancet Neurology
Neurology
2017English

Multiple-Time-Scale Framework for Understanding the Progression of Parkinson's Disease

Physical Review E
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy